Trial Will Test Calcitriol on Bone Health; Now Recruiting in Boston
A Phase 1 trial is enrolling children and adults with X‐linked hypophosphatemia (XLH) to assess the effects of calcitriol, the active form of vitamin D, on kidney function and bone health. Already underway at Massachusetts General Hospital, in Boston, the trial (NCT03748966) is looking to recruit 20…